HeartFocus, the AI-enabled echocardiography software from medical technology company DESKi, announces the release of the HeartFocus educational app in partnership with digital ultrasound company butterfly network.
The HeartFocus app aims to rapidly improve healthcare professionals’ ability to master 10 key cardiac views with confidence and clinical precision through customized, self-paced, AI-powered learning. Masu.
According to the company, medical professionals, medical schools, clinics, and health systems can access the HeartFocus Education app using the Butterfly iQ3 and iQ+ probes running on iOS iPads.
For a short period, end users can use DESKi’s customer portal to sign up and claim a free six-month license for the app. Available throughout the United States and 22 other countries.
“AI-powered heart scanning is the stethoscope of tomorrow, and the HeartFocus Education app helps put the tool in the hands of all medical professionals,” DESKi CEO Bertrand Moal said in a statement. .
“We designed an educational platform that makes lifesaving echo easy to learn, and we’re proud to partner with the Butterfly Network to bring it to as many healthcare professionals and educators as possible.”
Darius Shahida, Butterfly Network’s chief strategy officer, said HeartFocus is set to have a major impact on cardiac care and that Butterfly Network will partner with DESKi on what he calls a pioneering educational platform. “I’m excited,” he said.
“By combining our cutting-edge ultrasound technology with HeartFocus’ AI-powered training, we are breaking down barriers to cardiac care and enabling more practitioners to learn how to provide critical diagnostics on the spot. ” Shahida said in a statement.
bigger trends
HeartFocus joined in June Butterfly Garden is an AI marketplace launched by Butterfly Network. Through a subsequent agreement, HeartFocus integrated and released its patented AI-powered software with Butterfly’s single-probe whole-body handheld ultrasound system.
In August, Butterfly Network reported Q2 2024 Revenues were $21.5 million, an increase of 16% year over year, and net loss was $15.7 million, a decrease of 45% compared to $28.7 million in the prior year period.
Operating expenses were $29.8 million, down 29% from $42.2 million in the second quarter of 2023. Adjusted EBITDA was a loss of $8.1 million compared to $17 million in the prior year period.
In March, Butterfly Network achieved The EU MDR certification of the Butterfly IQ+ ultrasound system will enable the company to release products such as an AI-enabled automatic B-line counter and pulse wave Doppler (PWD) software to the European market.
Auto B-line Counter leverages AI to help healthcare professionals take into account patient abnormalities by measuring B-lines. B lines appear as bright lines on ultrasound and are associated with conditions such as COPD.
In 2023, the Butterfly Network will A five-year joint development collaboration with Forest Neurotech has developed a whole-brain neural interface utilizing Butterfly’s Ultrasound-on-Chip technology. The five-year co-development agreement includes a $20 million payment to Butterfly, which includes annual license fees, milestone payments and chip purchases.
